characteristics.text: SAMN48670775
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2025-05-21T16:22:03.547Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-12-04T23:45:29.437Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS27328216
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS27328216
characteristics.characteristic: SRA accession
characteristics.text: DNA
characteristics.characteristic: analyte type
characteristics.text: NCI_AntiPD1_RefractoryMelanoma
characteristics.characteristic: biospecimen repository
characteristics.text: PT0752_ARCHIVAL_WES
characteristics.characteristic: biospecimen repository sample id
characteristics.text: NA
characteristics.characteristic: body site
characteristics.text: phs004054
characteristics.characteristic: gap_accession
characteristics.text: 7807989
characteristics.characteristic: gap_sample_id
characteristics.text: 5810682
characteristics.characteristic: gap_subject_id
characteristics.text: Melanoma
characteristics.characteristic: histological type
characteristics.text: Yes
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: male
characteristics.characteristic: sex
characteristics.text: Clinical Trial
characteristics.characteristic: study design
characteristics.text: Biopsy Analysis of Trial S1616: Ipilimumab Plus Nivolumab versus Ipilimumab Alone in Patients with Anti-PD-1-Refractory Melanoma
characteristics.characteristic: study name
characteristics.text: PT0752_ARCHIVAL_WES
characteristics.characteristic: submitted sample id
characteristics.text: PT0752
characteristics.characteristic: submitted subject id
characteristics.text: NCI_AntiPD1_RefractoryMelanoma
characteristics.characteristic: submitter handle
characteristics.text: Tumor DNA sample from NA of a human male participant in the dbGaP study "Biopsy Analysis of Trial S1616: Ipilimumab Plus Nivolumab versus Ipilimumab Alone in Patients with Anti-PD-1-Refractory Melanoma"
characteristics.characteristic: title